NEW YORK, July 10, 2007 – Bruckmann, Rosser, Sherrill & Co., LLC (BRS), announced today a distribution to investors resulting from the recapitalization of Seroyal. Seroyal, based in Richmond Hill, Ontario, is a leading marketer and distributor of nutritional supplements and homeopathic remedies to health care practitioners throughout the Canada and the U.S. BRS acquired Seroyal in partnership with management in December 2004. The recapitalization resulted in a distribution equivalent to 59% of BRS’s original investment and BRS continues to own a majority position in Seroyal.
BRS, founded in 1995 and headquartered in New York, specializes in management buyouts and recapitalizations of high quality, middle market companies with strong market positions and/or growth potential. BRS currently manages approximately $1.4 billion of committed capital in three institutional private equity funds. The principals of BRS have worked together since the mid-1980s (originally at Citicorp Venture Capital) and have collectively invested in over 60 companies with a total value in excess of $12.6 billion. BRS currently has investments focused predominantly in the consumer products and services areas. For more information, visit www.brs.com.
CONTACT: Paul Kaminski – Bruckmann, Rosser, Sherrill & Co., 212-521-3700
E-MAIL: [email protected]